Calian Group (TSE:CGY - Get Free Report) had its target price lowered by analysts at Desjardins from C$62.00 to C$59.00 in a research report issued on Thursday,BayStreet.CA reports. The brokerage presently has a "buy" rating on the stock. Desjardins' price target points to a potential upside of 24.21% from the stock's previous close.
Other research analysts also recently issued research reports about the stock. Ventum Financial set a C$60.00 price objective on shares of Calian Group and gave the stock a "buy" rating in a report on Wednesday, June 11th. Canaccord Genuity Group lowered their price objective on shares of Calian Group from C$75.00 to C$60.00 and set a "buy" rating on the stock in a report on Thursday, May 22nd. Royal Bank Of Canada lowered their price objective on shares of Calian Group from C$60.00 to C$58.00 and set an "outperform" rating on the stock in a report on Thursday, May 22nd. Finally, CIBC upped their price objective on shares of Calian Group from C$50.00 to C$59.00 in a report on Monday, July 21st.
Get Our Latest Stock Report on Calian Group
Calian Group Stock Down 2.9%
Shares of TSE CGY traded down C$1.44 during trading on Thursday, hitting C$47.50. 20,079 shares of the company traded hands, compared to its average volume of 35,334. The business's fifty day moving average is C$49.04 and its 200 day moving average is C$45.91. Calian Group has a fifty-two week low of C$37.70 and a fifty-two week high of C$53.36. The firm has a market capitalization of C$563.87 million, a price-to-earnings ratio of 50.86, a P/E/G ratio of 2.50 and a beta of 0.88. The company has a debt-to-equity ratio of 39.54, a quick ratio of 1.20 and a current ratio of 1.29.
Insider Activity at Calian Group
In other news, Senior Officer Kevin Lee Ford bought 1,000 shares of the stock in a transaction dated Monday, May 26th. The stock was bought at an average price of C$38.05 per share, for a total transaction of C$38,050.00. Insiders have bought a total of 2,934 shares of company stock valued at $116,566 in the last three months. Corporate insiders own 0.63% of the company's stock.
Calian Group Company Profile
(
Get Free Report)
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calian Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calian Group wasn't on the list.
While Calian Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.